PMID: 8598518Jan 1, 1996Paper

Estimating the costs attributable to a disease with application to ovarian cancer

Journal of Clinical Epidemiology
Ruth EtzioniM Baker

Abstract

This article is concerned with the methodological issues that arise when estimating the expected costs attributable to a disease. In particular, the article considers methods appropriate for handling incomplete or censored cost and survival data, incorporating discounting, and computing attributable costs. After motivating the need for an estimate of the average, present value of the attributable costs, we present the Kaplan-Meier sample-average (KMSA) estimator, which takes into account the censored nature of the data that are typically available. We investigate the statistical properties of the estimator and compare it to others employed in the literature, showing how certain methods for incorporating discounting can introduce bias. We demonstrate the utility of the estimator by applying it to estimation of the costs attributable to ovarian cancer, using data from a database linking Medicare claims with the Surveillance, Epidemiology, and End Results cancer registry. Our analysis suggests that the average, present value of the 15-year costs attributable to ovarian cancer is $21,285 for local-stage cases and $32,126 for distant-state cases in 1990 dollars.

References

Mar 31, 1977·The New England Journal of Medicine·M C Weinstein, W B Stason
Jan 1, 1991·Medical Care·M S BakerR C Smucker
Aug 1, 1989·American Journal of Public Health·E B KeelerJ Wasserman
Mar 17, 1989·JAMA : the Journal of the American Medical Association·W G ManningJ Wasserman
Apr 15, 1993·The New England Journal of Medicine·J D Lubitz, G F Riley

❮ Previous
Next ❯

Citations

Sep 27, 2002·Statistics in Medicine·Mark A HlatkyIain M Johnstone
Mar 29, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Hui-Chu Lang, Shi-Liang Wu
Aug 1, 1997·Mathematical Biosciences·O ZhengD W Gaylor
Oct 28, 1999·Journal of Health Economics·R D EtzioniS D Ramsey
Mar 15, 2000·Controlled Clinical Trials·D Ghosh
Oct 30, 2007·Nature Clinical Practice. Oncology·K Robin YabroffMartin L Brown
Aug 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·S F HurleyD B Evans
Sep 23, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Scott D RamseyLauren Clarke
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T D SzucsK J Dedes
Jun 3, 1999·Annual Review of Public Health·P DiehrD Y Lin
Mar 7, 2008·Onkologie·Michael HartmannChristin Gundermann
May 25, 2011·BMC Cancer·Misericordia CarlesMontserrat Rue
Jun 22, 2012·ClinicoEconomics and Outcomes Research : CEOR·Harindra C WijeysunderaMurray D Krahn
Nov 28, 2012·Patient Related Outcome Measures·Preetinder Singh Gill, Billy Whisnant
Dec 6, 2005·Drugs & Aging·Kathleen LangJoseph Menzin
Sep 9, 2008·Applied Health Economics and Health Policy·Hui-Chu LangShi-Liang Wu
Jan 27, 2005·Radiology·Molly T BeinfeldG Scott Gazelle
Oct 14, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kathleen LangJoseph Menzin
Mar 26, 2003·Statistics in Medicine·D Y Lin
Mar 15, 2012·Cancer·Caitriona B O'NeillElena B Elkin
Sep 13, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Christine A PollicinoPeter C O'Brien
Aug 5, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Tron A MogerEline Aas
Apr 5, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joseph MenzinJerome Wilson
Sep 12, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jalpa A DoshiDaniel Polsky
Sep 15, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Elisabeth FenwickAdrian R Levy
Sep 12, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·William F McGhanDonna Rindress
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Janice N CormierXianglin L Du
Oct 31, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·S D RamseyN Urban
Jun 3, 2017·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Charu TanejaGerry Oster
Jun 19, 2009·Medical Care·Deborah A Marshall, Margaret Hux
May 15, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Kun KimNahila Justo
Mar 8, 2019·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Charu TanejaGerry Oster

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.